<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34981221</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1432-1459</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>269</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of neurology</Title>
          <ISOAbbreviation>J Neurol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Splicing in two skeletal muscle transcripts correlates with clinical phenotype in myotonic dystrophy type 1 patients.</ArticleTitle>
        <Pagination>
          <StartPage>2784</StartPage>
          <EndPage>2787</EndPage>
          <MedlinePgn>2784-2787</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-021-10917-8</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sedehizadeh</LastName>
            <ForeName>Saam</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK. saam.sedehizadeh@nhs.net.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wojciechowska</LastName>
            <ForeName>Marzena</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Genetics, Institute of Bioorganic Chemistry, Polish Academy of Sciences, 61-704, Poznan, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ketley</LastName>
            <ForeName>Ami</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brook</LastName>
            <ForeName>J David</ForeName>
            <Initials>JD</Initials>
            <AffiliationInfo>
              <Affiliation>School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maddison</LastName>
            <ForeName>Paul</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>G0802629</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>J Neurol</MedlineTA>
        <NlmUniqueID>0423161</NlmUniqueID>
        <ISSNLinking>0340-5354</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009223" MajorTopicYN="Y">Myotonic Dystrophy</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>13</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34981221</ArticleId>
        <ArticleId IdType="doi">10.1007/s00415-021-10917-8</ArticleId>
        <ArticleId IdType="pii">10.1007/s00415-021-10917-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Harper PS, Brook JD, Newman E. Myotonic dystrophy. London; New York: W.B. Saunders; 2001.</Citation>
        </Reference>
        <Reference>
          <Citation>Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H et al (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3’ end of a transcript encoding a protein kinase family member. Cell 68(4):799–808</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0092-8674(92)90154-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Philips AV, Timchenko LT, Cooper TA (1998) Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280(5364):737–741</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.280.5364.737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wheeler TM, Leger AJ, Pandey SK, MacLeod AR, Nakamori M, Cheng SH et al (2012) Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 488(7409):111–115</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature11362</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang G-S, Cooper TA (2007) Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet 8(10):749–761</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrg2164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakamori M, Sobczak K, Puwanant A, Welle S, Eichinger K, Pandya S et al (2013) Splicing biomarkers of disease severity in myotonic dystrophy. Ann Neurol 74(6):862–872</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ana.23992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Index IDMC-10. Programme at a glance 17. Poster Presentation Abstracts 95 Author index 218 Attendees Contact Information 245 Notes PDF [Internet]. [cited 2018 Sep 17]. Available from: https://docplayer.net/27797227-Index-idmc-10-programme-at-a-glance-17-poster-presentation-abstracts-95-author-index-218-attendees-contact-information-245-notes-260.html</Citation>
        </Reference>
        <Reference>
          <Citation>Mendell JR, Florence J (1990) Manual muscle testing. Muscle Nerve 13(Suppl):S16-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mus.880131307</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hébert LJ, Remec J-F, Saulnier J, Vial C, Puymirat J (2010) The use of muscle strength assessed with handheld dynamometers as a non-invasive biological marker in myotonic dystrophy type 1 patients: a multicenter study. BMC Musculoskelet Disord 11:72</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2474-11-72</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bouchard J-P, Cossette L, Bassez G, Puymirat J (2015) Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases. J Neurol 262(2):285–293</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-014-7570-x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kierkegaard M, Tollbäck A (2007) Reliability and feasibility of the six minute walk test in subjects with myotonic dystrophy. Neuromuscul Disord NMD 17(11–12):943–949</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nmd.2007.08.003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strothotte S, Strigl-Pill N, Grunert B, Kornblum C, Eger K, Wessig C et al (2010) Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. J Neurol 257(1):91–97</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-009-5275-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Henricson E, Abresch R, Han JJ, Nicorici A, Goude Keller E, de Bie E et al (2013) The 6-minute walk test and person-reported outcomes in boys with Duchenne muscular dystrophy and typically developing controls: longitudinal comparisons and clinically-meaningful changes over one year. PLoS Curr 8:5</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
